Literature DB >> 6920936

HLA antigens and Bf allotypes in SLE: evidence for the association being with specific haplotypes.

C M Black, K I Welsh, A Fielder, G R Hughes, J R Batchelor.   

Abstract

The clinical features and HLA types of 67 unrelated patients with Systemic Lupus Erythematosus (SLE) were analyzed. The results showed: 1. An increase in frequencies of A1, B8, and DR3. These antigens are in close linkage disequilibrium and our data show that susceptibility to SLE is associated with the presence of all three antigens, implicating the specific haplotype which bears these antigens. 2. An increase in frequency of DR2, but not A3 or B7, these latter two antigens being in linkage disequilibrium with DR2. 3. 73.3% of the 54 Caucasoid SLE group were either B8 and/or DR2. This is in comparison with 37.5% in the controls and the difference is significant (p less than 0.001). 4. There was no association apparent between extent of disease, particular organ involvement and level of circulating antibodies to double stranded DNA with any HLA region product.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6920936     DOI: 10.1111/j.1399-0039.1982.tb01426.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  12 in total

Review 1.  The role of common protective alleles HLA-DRB1*13 among systemic autoimmune diseases.

Authors:  H Furukawa; S Oka; N Tsuchiya; K Shimada; A Hashimoto; S Tohma; A Kawasaki
Journal:  Genes Immun       Date:  2016-11-10       Impact factor: 2.676

Review 2.  Inclusion body myositis.

Authors:  M J Garlepp; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

3.  HLA associations with inclusion body myositis.

Authors:  M J Garlepp; B Laing; P J Zilko; W Ollier; F L Mastaglia
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

4.  Genetics of systemic lupus erythematosus.

Authors:  G R Hughes; J R Batchelor
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05

5.  Association of class I, II, and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study.

Authors:  K Hartung; A Fontana; M Klar; H Krippner; K Jörgens; B Lang; H H Peter; W J Pichler; D Schendel; M Robin-Winn
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

Review 6.  Unraveling the genetics of systemic lupus erythematosus.

Authors:  John B Harley; Jennifer A Kelly; Kenneth M Kaufman
Journal:  Springer Semin Immunopathol       Date:  2006-09-22

7.  Extractable nuclear antigen (ENA) autoantibodies in SLE: an immunogenetic relationship with HLA, C4 and Bf alleles.

Authors:  R S Warlow; G Uko; J McCluskey; P H Kay; F T Christiansen; R L Dawkins
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

8.  SLE-like and sicca symptoms in late component (C9) complement deficiency.

Authors:  M Sugimoto; M Nishikai; A Sato; Y Suzuki; M Nihei; J Uchida; N Mimura
Journal:  Ann Rheum Dis       Date:  1987-02       Impact factor: 19.103

Review 9.  Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.

Authors:  Manfred Relle; Andreas Schwarting
Journal:  Clin Dev Immunol       Date:  2012-06-19

10.  HLA antigens in Malay patients with systemic lupus erythematosus: association with clinical and autoantibody expression.

Authors:  M R Azizah; S S Ainol; N C Kong; Y Normaznah; M N Rahim
Journal:  Korean J Intern Med       Date:  2001-06       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.